Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. - Wikidata - awgldk - TriplyDB

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

http://www.wikidata.org/entity/Q35147059

about

Suppression of breast tumor growth and metastasis by an engineered transcription factor The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices The natural tumor suppressor protein maspin and potential application in non small cell lung cancer Maspin is not required for embryonic development or tumour suppression Targeting tumor-stromal interactions in bone metastasis Inflammation and skeletal metastasis Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate The role of PTEN in prostate cancer cell tropism to the bone micro-environment.Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.A seemingly most effective target for early detection and intervention of prostate tumor invasion.Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway.Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.Maspin expression in prostate tumor elicits host anti-tumor immunity Identification of phosphorylation sites on extracellular corneal epithelial cell maspin Identification of an intrinsic determinant critical for maspin subcellular localization and function.Maspin and MCM2 immunoprofiling in salivary gland carcinomas Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs)Epigenetic reprogramming of cancer cells via targeted DNA methylation.Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity.Causes and consequences of DNA hypomethylation in human cancer.Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes.Targeting maspin in endothelial cells to induce cell apoptosis.Role of maspin in cancer.Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.Bad seeds produce bad crops: a single stage-process of prostate tumor invasion.Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells Correlated alterations in prostate basal cell layer and basement membrane Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT.The secretion and biological function of tumor suppressor maspin as an exosome cargo protein.Modulators of the urokinase-type plasminogen activation system for cancer.An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis.Maspin: molecular mechanisms and therapeutic implications.

P2860

Q21135222-66EDD3DC-ED86-4BB5-BD90-045AEFA68296 Q24323082-8588FF61-B6C3-4630-A22F-06A1AE552F8A Q24604273-6C4B0A55-C3DA-4FE8-90FA-9BDCC0564F3D Q24612315-447F9410-B56F-4629-AFB1-39A42904F6AB Q27024561-8B65CF0E-D1F1-4312-A648-708B6DFB75DD Q28396089-09DE490A-0EC3-4D25-92F2-D12EED59FF87 Q28585170-466031F9-9CAF-470E-A74D-5B0A24CB5F3C Q30443138-7F6482B7-BF75-4506-BB18-4CBDFF80C9F0 Q31158946-EECC4E8A-C1BA-4E62-812A-9FA9DD17FDED Q33218589-B4E22465-77C6-4C0D-938A-3912D7FFAFA8 Q33220470-A98B2905-0E0F-4308-BF4A-AB83A6ACE4E8 Q33690450-31EEAA14-0F6D-48F1-A9C1-4B3562B191CE Q33863314-0F6790E4-0FDD-48F1-BE60-B89E46BA5328 Q34097244-D3CBCE96-B949-4616-BC90-D74A422004DC Q34186534-CBF1FD71-CC11-4263-B532-19386646A8C7 Q34768332-C15197D6-D419-4504-8FD3-DDB289BB111D Q34956706-EB4DE5B7-AE18-475A-83F2-8BA619FB0E93 Q34992612-CFA90539-DAD7-4741-9F27-655E87E2B803 Q35053115-BE5CE8EC-C428-4228-9B48-AD23965B6F97 Q35318944-4FF7AB2B-4789-4538-83FC-59DB3CB471E9 Q35754831-402A7587-DC59-4C9F-BD49-07A9EAC32109 Q36012682-838F60C1-1C5C-48B4-9665-CC8E72F5E8E6 Q36047094-D5110A18-3CA4-4F26-B127-FB959F6E189B Q36070523-18909DAF-CC44-4AB3-852B-92F513133BC8 Q36164751-DF376960-AFCA-4A18-B91F-D19BE5A7A1C4 Q36190977-657A3B89-6022-474D-8281-8EF80A0BB65D Q36481059-595DD7A9-AD9A-4405-9DAF-8ACA595EB25A Q36698729-4B7EEFAE-1F1C-40A3-8BFE-133DCB378F40 Q36707418-2BD29A59-7087-45D2-98B1-EF4DB9207CCE Q36728257-E6D1D5B4-B2F8-4F76-9782-DA481646726B Q36805290-A1D9D6B0-E0F3-4CD7-BF96-A63BC17F9074 Q36844480-C9354630-6282-4D40-A1E8-741D818E958A Q36867359-2DD6D61C-92C0-47A6-836A-63D199E3AB83 Q36983836-73D37138-8D68-4A50-85C6-15E46FC62A39 Q37148300-0BDF475B-373E-478B-B116-252FEEFCF7C3 Q37302354-E2757AF3-4F55-44E7-AB28-C7578333A285 Q37702658-F742C3A9-051B-4BDD-8556-51D4C68962F5 Q37733590-8670C1E7-B4DE-4A6B-B70A-33C45D552961 Q37952002-E4CF5B6D-EE08-4FEE-929A-7E77598CCF74 Q38023237-37800759-3097-4BDA-9C83-CD8F51E354EC

P2860

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

http://www.wikidata.org/entity/Q35147059

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@ast

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@en

type

label

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@ast

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@en

prefLabel

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@ast

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@en

P1433

Q35147059-969C4C9E-73C7-4A0A-8047-7984C77A2B4B

P1476

Q35147059-815787B4-D6E2-4DF5-8CBF-41656551D3B7

P2093

Q35147059-050BE8A4-1494-403B-8810-4C23DC49C4D3

Q35147059-0918E98E-31D1-47C4-9D00-DF7DF671C9F6

Q35147059-36D0FCC6-C7B7-42AF-B1FE-6D6825C9C00D

Q35147059-4861657C-FCF3-461C-8C64-51B93F931B28

Q35147059-56A769CD-03B2-46C5-83B0-A95C522FF3B7

Q35147059-5775F0A6-E5D9-421C-94BB-811D6AA208BE

Q35147059-71F27B85-9481-498F-8142-887AABE0AE93

Q35147059-80950050-263C-4B8F-B474-A3F93D378908

Q35147059-9DF14D60-F239-4072-A5E7-7639CB9E877E

Q35147059-D59C5C78-CD5F-45F1-AB38-3B9DA78270D1

P2860

Q35147059-0880D652-712D-4AE3-9A85-8D9FCC07D6B3

Q35147059-08E007DC-E78D-443F-98A7-C3E5985DD54D

Q35147059-0C983DB7-0399-455B-B935-8D55B06163AF

Q35147059-1C870B68-9344-4497-940A-5C78038961DC

Q35147059-1E0BEC5B-478D-407D-A46B-454945DA5B05

Q35147059-23A8E1AA-0EC7-4209-A8A7-28E533929D0E

Q35147059-23AE2C19-FB37-4DF0-A1E2-704631298B31

Q35147059-25517476-64D4-4AB7-A7B2-1E0B94A1AC16

Q35147059-257656EC-F9A0-4079-BF21-C519CF6FD117

Q35147059-379226E6-18C0-4130-8BA7-16819FE2B83F

P304

Q35147059-0218AF53-45BC-4576-8068-4C1D14CD19D1

P31

Q35147059-C6A4FA8E-4D26-47A8-8DB4-CF437B6F875C

P356

Q35147059-7C1A8CE5-E335-4E53-9276-56D0AFE849D9

P407

Q35147059-9029D2F5-D2A8-4C42-AC4D-3E86AF2A3866

P433

Q35147059-0761BE78-E0BC-4713-8301-676E0CAC5811

P478

Q35147059-12937697-1A71-40B7-BFED-AFD6115C4FE5

P577

Q35147059-68D3AFE0-43B0-4260-9C97-A278AB9BA536

P5875

Q35147059-C2A7AD39-C752-47B1-99B3-EC7D8EF3EB90

P698

Q35147059-65E78080-782C-4FD4-ABEF-D4EA7CBC5E81

P932

Q35147059-85A94BA9-8268-4C87-B898-741C9941084E

P356

PNAS.1331360100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Maspin expression inhibits ost ...... ostate cancer bone metastasis.

@en

P2093

Hector R Biliran

http://www.w3.org/2001/XMLSchema#string

Jaron Lockett

http://www.w3.org/2001/XMLSchema#string

Judith Abrams

http://www.w3.org/2001/XMLSchema#string

Michael L Cher

http://www.w3.org/2001/XMLSchema#string

Michael Zachareas

http://www.w3.org/2001/XMLSchema#string

Mingxin Che

http://www.w3.org/2001/XMLSchema#string

Rafael Fridman

http://www.w3.org/2001/XMLSchema#string

Shijie Sheng

http://www.w3.org/2001/XMLSchema#string

Sunita Bhagat

http://www.w3.org/2001/XMLSchema#string

Yonghong Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

Maspin inhibits cell migration in the absence of protease inhibitory activity

Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin

Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen

Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface

Metastasis to bone: causes, consequences and therapeutic opportunities

Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin.

P304

7847-7852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1331360100

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10723400

http://www.w3.org/2001/XMLSchema#string

P698

12788977

http://www.w3.org/2001/XMLSchema#string

P932

164676

http://www.w3.org/2001/XMLSchema#string